✦ LIBER ✦

714 - Phase II trial of paclitaxel (P) and cisplatin (COOP) in patients with advanced breast cancer refractory to anthracycline (A) therapy

✍ Scribed by F. Riccardi; G. Rosati; M. Biglietto; G. Cartenì; P. De Rosa; A. Tucci; G. Pacilio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of etoposide, cisplatin

✍ Jouve, M.; Dorval, T.; Mosseri, V.; Palangie, T.; Beuzeboc, P.; Garcia-Giralt, E 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 144 KB

P316 Phase II study of weekly albumin-bo

✍ X. Hu; B. Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Preliminary results of a phase I/II tria

✍ C. Bokemeyer; H. -J. Schmoll; F. Natt; M. Knoche; J. Beyer; R. Souchon 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 387 KB

Promising activity with eniluracil (776C

✍ Jensen, T.Skovsgaard; Davidson, N.; Piccart, M.J.; Richel, D.J.; Harris, D.T.; B 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Phase I–II trial of prolonged gemcitabin

✍ Patrizia Vici; Alessandra Fabi; Giulio Metro; Domenico Sergi; Diana Giannarelli; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 204 KB

A Phase II study of IncelTM (biricodar,

✍ Toppmeyer, D.; Seidman, A.; Overmoyer, B.; Pollak, M.; Verma, S.; Russell, C.; T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 170 KB